Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-018156

Director sold 15,314 shares at $41.78 ($639,819)

  • Director acquired 15,314 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FOOTE SUSAN BARTLETT · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-05-11 Exercise or conversion : show line 1 in the form +7,118 $34.41 $244,895 23,529 D
2017-05-11 Exercise or conversion : show line 2 in the form +8,196 $36.37 $298,089 31,725 D
2017-05-11 Sale : show line 3 in the form −15,314 $41.78 $639,819 13,251 D
Open-market sales · 15,314 sh · avg $41.78 · $639,819

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-05-11 Exercise or conversion : show line 4 in the form Non-qualified Stock Option (Right to Buy) −7,118 0 D
2017-05-11 Exercise or conversion : show line 5 in the form Non-qualified Stock Option (Right to Buy) −8,196 0 D
Loading xslF345X03/form4.xml…